IL-6 as a Mediator of the Association Between Traditional Risk Factors and Future Myocardial Infarction
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IL-6 as a Mediator of the Association Between Traditional Risk Factors and Future Myocardial Infarction
Authors
Keywords
-
Journal
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Volume -, Issue -, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2021-03-04
DOI
10.1161/atvbaha.120.315793
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Analysis of the genetic variants associated with circulating levels of sgp130. Results from the IMPROVE study
- (2020) Alice Bonomi et al. GENES AND IMMUNITY
- Global Transcriptional Profiling Reveals Novel Autocrine Functions of Interleukin 6 in Human Vascular Endothelial Cells
- (2020) Liza U. Ljungberg et al. MEDIATORS OF INFLAMMATION
- IL-6 trans-Signaling Impairs Sprouting Angiogenesis by Inhibiting Migration, Proliferation and Tube Formation of Human Endothelial Cells
- (2020) Mulugeta M Zegeye et al. Cells
- Reassessing the Mechanisms of Acute Coronary Syndromes
- (2019) Peter Libby et al. CIRCULATION RESEARCH
- Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1β inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis
- (2019) Paul M Ridker et al. EUROPEAN HEART JOURNAL
- A Mendelian randomization study of IL6 signaling in cardiovascular diseases, immune-related disorders and longevity
- (2019) Mickael Rosa et al. npj Genomic Medicine
- Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
- (2019) Jean-Claude Tardif et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hypertension and increased endothelial mechanical stretch promote monocyte differentiation and activation: roles of STAT3, interleukin 6 and hydrogen peroxide
- (2018) Roxana Loperena et al. CARDIOVASCULAR RESEARCH
- OUP accepted manuscript
- (2018) CARDIOVASCULAR RESEARCH
- Activation of the JAK/STAT3 and PI3K/AKT pathways are crucial for IL-6 trans-signaling-mediated pro-inflammatory response in human vascular endothelial cells
- (2018) Mulugeta M. Zegeye et al. Cell Communication and Signaling
- Plasma interleukin 6 levels are associated with cardiac function after ST-elevation myocardial infarction
- (2018) Hilde E. Groot et al. Clinical Research in Cardiology
- Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
- (2018) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biomarkers in cardiovascular disease: Statistical assessment and section on key novel heart failure biomarkers
- (2017) Ravi Dhingra et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Discovery of a junctional epitope antibody that stabilizes IL-6 and gp80 protein:protein interaction and modulates its downstream signaling
- (2017) Ralph Adams et al. Scientific Reports
- IL-6, TNF-α, and IL-10 levels/polymorphisms and their association with type 2 diabetes mellitus and obesity in Brazilian individuals
- (2017) Kathryna Fontana Rodrigues et al. Archives of Endocrinology Metabolism
- Mediation Analysis: A Practitioner's Guide
- (2016) Tyler J. VanderWeele Annual Review of Public Health
- Circulating levels of interleukin 6 soluble receptor and its natural antagonist, sgp130, and the risk of myocardial infarction
- (2015) Ilais Moreno Velásquez et al. ATHEROSCLEROSIS
- Inflammation and plaque vulnerability
- (2015) G. K. Hansson et al. JOURNAL OF INTERNAL MEDICINE
- Statistical mediation analysis with a multicategorical independent variable
- (2013) Andrew F. Hayes et al. BRITISH JOURNAL OF MATHEMATICAL & STATISTICAL PSYCHOLOGY
- Targeting Interleukin-6 in Rheumatoid Arthritis
- (2013) Md Yuzaiful Md Yusof et al. DRUGS
- Targeting interleukin-6 in inflammatory autoimmune diseases and cancers
- (2013) Xin Yao et al. PHARMACOLOGY & THERAPEUTICS
- Endothelial dysfunction and hypertension in aging
- (2012) Yukihito Higashi et al. HYPERTENSION RESEARCH
- IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6
- (2012) Stefan Rose-John International Journal of Biological Sciences
- Targeting Interleukin-6: All the Way to Treat Autoimmune and Inflammatory Diseases
- (2012) Toshio Tanaka et al. International Journal of Biological Sciences
- Association of interleukin-6 circulating levels with coronary artery disease: A meta-analysis implementing mendelian randomization approach
- (2012) Wenquan Niu et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The interleukin-6 pathway and atherosclerosis
- (2012) S Matthijs Boekholdt et al. LANCET
- The interleukin 6 pathway and atherosclerosis
- (2012) Jürgen Scheller et al. LANCET
- Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
- (2012) LANCET
- The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
- (2012) LANCET
- C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Inflammation and Hypertension: The Interplay of Interleukin-6, Dietary Sodium, and the Renin-Angiotensin System in Humans
- (2011) B. Chamarthi et al. AMERICAN JOURNAL OF HYPERTENSION
- The pro- and anti-inflammatory properties of the cytokine interleukin-6
- (2011) Jürgen Scheller et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Cytokines present in smokers' serum interact with smoke components to enhance endothelial dysfunction
- (2011) Silvia S. Barbieri et al. CARDIOVASCULAR RESEARCH
- Haemostatic and inflammatory markers are independently associated with myocardial infarction in men and women
- (2011) Patrik Wennberg et al. THROMBOSIS RESEARCH
- Ligand binding assays at equilibrium: validation and interpretation
- (2010) Edward C. Hulme et al. BRITISH JOURNAL OF PHARMACOLOGY
- Interleukin-6 Signaling in Liver-Parenchymal Cells Suppresses Hepatic Inflammation and Improves Systemic Insulin Action
- (2010) F. Thomas Wunderlich et al. Cell Metabolism
- The Västerbotten Intervention Programme: background, design and implications
- (2010) Margareta Norberg et al. Global Health Action
- Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the Community
- (2009) Olle Melander JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- How much is too much? Interleukin-6 and its signalling in atherosclerosis
- (2009) Harald Schuett et al. THROMBOSIS AND HAEMOSTASIS
- Relation of smoking status to a panel of inflammatory markers: The Framingham offspring
- (2008) Yamini S. Levitzky et al. ATHEROSCLEROSIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now